Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-01-01 @ 9:42 AM
Study NCT ID:
NCT03671603
Status:
COMPLETED
Last Update Posted:
2022-01-11
First Post:
2018-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
Sponsor:
GE Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-13
First Submit QC Date:
None
Study First Post Date:
2018-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-06
Last Update Post Date:
2022-01-11
Last Update Post Date Type:
ACTUAL